UCP1 and rheumatoid arthritis: Secondary objectives were (a) to describe effect of anti-rheumatic treatment on UCP1 expression; (b) to define if UCP1 expression improves estimation of CV risk in RA patients; (c) and finally, to demonstrate if UCP1 expression contributes to reduction of actual CV events.